EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties

Alexandra Rak iD, Yana Zabrodskaya iD, Pei-Fong Wong iD, Irina Isakova-Sivak iD

Antibodies · 22.12.2025 · 15 (1) · 2

DOI: 10.3390/antib15010002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibodies, online erschienen am 22.12.2025. Verfasst von Alexandra Rak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Depatment of Virology and Immunology, Institute of Experimental Medicine, 197022 Saint Petersburg, Russia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Notwithstanding the declaration by the World Health Organization in May 2023 regarding the conclusion of the COVID-19 pandemic, new cases of this potentially lethal infection continue to be documented globally, exerting a sustained influence on the worldwide economy and social structures. Contemporary SARS-CoV-2 variants, while associated with a reduced propensity for severe acute pathology, retain the capacity to induce long-term post-COVID syndrome, including in ambulatory patient populations. This clinical phenomenon may be attributable to potential autoimmune reactions hypothetically triggered by antiviral antibodies, thereby underscoring the need for developing novel, universal vaccines against COVID-19. The nucleocapsid protein (N), being one of its most conserved and highly immunogenic components of SARS-CoV-2, presents a promising target for such investigative efforts. However, the protective role of anti-N antibodies, generated during natural infection or through immunization with N-based vaccines, alongside the potential adverse effects associated with their production, remains to be fully elucidated. In the present study, we aim to identify potential sites of homology in structures or sequences between the SARS-CoV-2 N protein and human antigens detected using hyperimmune sera against N protein obtained from mice, rabbits, and hamsters.

Methods

We employed Western blot analysis of lysates from human cell lines (MCF7, HEK293T, THP-1, CaCo2, Hep2, T98G, A549) coupled with mass spectrometric identification to assess the cross-reactivity of polyclonal and monoclonal antibodies generated against recombinant SARS-CoV-2 N protein with human self-antigens.

Results

We showed that anti-N antibodies developed in mice and rabbits exhibit pronounced immunoreactivity towards specific components of the human proteome. In contrast, anti-N immunoglobulins from hamsters showed no non-specific cross-reactivity with either hamster or human proteomic extracts because of the lack of autoreactivity or immunogenicity differences. Subsequent mass spectrometric analysis of the immunoreactive bands identified principal autoantigenic targets, which were predominantly heat shock proteins (including HSP90-beta, HSP70, mitochondrial HSP60, and HSPA8), histones (H2B, H3.1–3), and key metabolic enzymes (G6PD, GP3, PKM, members of the 1st family of aldo-keto reductases).

Conclusions

The results obtained herein highlight the differences in the development of anti-N humoral responses in humans and in the Syrian hamster model. These data provide a foundational basis for formulating clinical recommendations to predict possible autoimmune consequences in COVID-19 convalescents and are of critical importance for the rational design of future N protein-based, cross-protective vaccine candidates against novel coronavirus infections.

Schlagwörter

Stichwörter der Autor:innen

COVID-19SARS-CoV-2antiviral antibodiesautoimmunitynucleocapsid proteinself-antigen

Autor:innen und Institutionen

  • Depatment of Virology and Immunology, Institute of Experimental Medicine, 197022 Saint Petersburg, Russia.
  • Department of Molecular Biology of Viruses, Smorodintsev Research Institute of Influenza, 197022 Saint Petersburg, Russia.

ORCID-Profile: Alexandra Rak, Yana Zabrodskaya, Pei-Fong Wong, Irina Isakova-Sivak

Förderung

  • Russian Science Foundation

Zitieren

APA

Rak, A., Zabrodskaya, Y., Wong, P. F., & Isakova-Sivak, I. (2025). Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties. Antibodies, 15(1), 2. https://doi.org/10.3390/antib15010002

Vancouver

Rak A, Zabrodskaya Y, Wong PF, Isakova-Sivak I. Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties. Antibodies. 2025;15(1):2. doi:10.3390/antib15010002

BibTeX
@article{Rak2025,
  author = {Rak, Alexandra and Zabrodskaya, Yana and Wong, Pei-Fong and Isakova-Sivak, Irina},
  title = {Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties},
  journal = {Antibodies},
  year = {2025},
  volume = {15},
  number = {1},
  pages = {2},
  doi = {10.3390/antib15010002}
}
Kostenlos starten →